covid_siam-pukkato
siam.pukkato / Shutterstock.com
10 June 2021

(WATCH) Lisa Ferri of Mayer Brown on the COVID-19 waiver

Talks over a COVID-19 vaccine waiver ended this week at the World Trade Organization (WTO) in Geneva, with an agreement to work towards a text-based response to the plan.

A WTO statement said all sides agreed to “engage constructively” in a discussion based on two proposals: the revised waiver and the European Union’s urgent trade policy responses, which includes greater use of compulsory licensing (more here).

In May, the Biden administration backed the original waiver, causing consternation among rights owners.

In early June, LSIPR spoke with Lisa Ferri, global co-chair of Mayer Brown’s IP practice and life sciences group about the US position and what it might mean for vaccine makers, pharma, and the international response to the pandemic.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
17 May 2021   The International Association for the Protection of Intellectual Property has released a position paper on the proposed COVID-19 IP waiver, claiming that it will have a negative impact on the existing frameworks for promoting international cooperation and access to vaccines.
Big Pharma
14 June 2021   French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.

More on this story

Big Pharma
17 May 2021   The International Association for the Protection of Intellectual Property has released a position paper on the proposed COVID-19 IP waiver, claiming that it will have a negative impact on the existing frameworks for promoting international cooperation and access to vaccines.
Big Pharma
14 June 2021   French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.

More on this story

Big Pharma
17 May 2021   The International Association for the Protection of Intellectual Property has released a position paper on the proposed COVID-19 IP waiver, claiming that it will have a negative impact on the existing frameworks for promoting international cooperation and access to vaccines.
Big Pharma
14 June 2021   French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.